Summary
The global CRISPR-Based Therapeutics Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2020.
Overview
Crispr/CRISPR-based Therapies promise to revolutionize medicine and have the potential to completely change how the disease is treated. The basic principle of this technology is to use genetic engineering to insert a piece of DNA that inhibits the proteinase K enzyme, which is one of the most common ways in which cells are damaged. Generally, when this enzyme is "cycled", it repairs the cell without harm, although with the CRISPR-based medicine, the damage to the cell can be repaired and the cycle repeats indefinitely. The global CRISPR-based therapeutics market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global CRISPR-based therapeutics market is expected to witness significant growth during the forecast period, owing to growing availability of CRISPR.
Market Drivers
Rising availability of government and private funding is expected to drive growth of the global CRISPR-based therapeutics market during the forecast period. Various private and government organizations are investing significantly to enhance R&D projects in CRISPR therapeutics. For instance, in October 2019, the National Institute of Health (NIH) awarded US$ 89 million for additional projects to advance genome editing to researchers across the U.S. and Canada. Furthermore, in August 2020, Synthego, a genome engineering company, raised US$ 100 million to accelerate the CRISPR platform. Hence, such factors are expected to drive growth of the global CRISPR-based therapeutics market during the forecast period. Furthermore, growing availability of CRISPR is expected to propel the global CRISPR-based therapeutics market growth over the forecast period.
Market Restraint
Challenges including ethical issues and lack of standardization are expected to hinder the global CRISPR-based therapeutics market growth over the forecast period.
Regional Insights
Among regions, North America is expected to witness significant growth in the global CRISPR-based therapeutics market during the forecast period. This is owing to expanding biopharmaceutical R&D activities across the region. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to increasing number of ongoing clinical trials.
Competitive Section
Major companies operating in the global CRISPR-based therapeutics market are CRISPR Therapeutics, Addgene, Intellia Therapeutics, Thermo Fisher Scientific, GE Healthcare Dharmacon, and Mirus Bio LLC.
For instance, in April 2021, Vertex Pharmaceuticals Inc. collaborated with CRISPR Therapeutics to develop, manufacture, and commercialize CTX001, an investigational CRISPR/Cas9-based gene editing therapy.
The CRISPR-Based Therapeutics Market report highlights product development and growth strategies such as mergers and acquisitions adopted by market players along with SWOT Analysis, PEST, and Porter’s Five Forces analyses of the CRISPR-Based Therapeutics Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Caribou Biosciences
- Addgene
- CRISPR THERAPEUTICS
- Merck KGaA
- Mirus Bio LLC
- Editas Medicine
- Takara Bio USA
- Thermo Fisher Scientific
- Horizon Discovery Group
- Intellia Therapeutics
- GE Healthcare Dharmacon
By Product Type, the market is primarily segmented into:
- Genome Editing
- Genetic Engineering
- gRNA Database/Gene Librar
- CRISPR Plasmid
- Human Stem Cells
- Genetically Modified Organisms/Crops
- Cell Line Engineering
By Applications, the market is segmented into:
- Biotechnology Companies
- Pharmaceutical Companies
- Academic Institutes
- Research and Development Institutes
The report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
The objective of the CRISPR-Based Therapeutics Market Report:
- To assess the size of the market by value and volume
- Analyze the CRISPR-Based Therapeutics Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the CRISPR-Based Therapeutics Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of-the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact the growth of the CRISPR-Based Therapeutics Market
The CRISPR-Based Therapeutics Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the CRISPR-Based Therapeutics Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type, and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CRISPR-Based Therapeutics Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global CRISPR-Based Therapeutics Market Share by Application: 2020 VS 2026
1.6 Coronavirus Disease 2019 (Covid-19) Impact: CRISPR-Based Therapeutics Market
1.6.1 How the Covid-19 is Affecting the CRISPR-Based Therapeutics Market
1.6.1.1 CRISPR-Based Therapeutics Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and CRISPR-Based Therapeutics Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 CRISPR-Based Therapeutics Market Perspective (2015-2026)
2.2 CRISPR-Based Therapeutics Market Growth Trends by Regions
2.2.1 CRISPR-Based Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CRISPR-Based Therapeutics Market Historic Market Share by Regions (2015-2020)
2.2.3 CRISPR-Based Therapeutics Market Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 CRISPR-Based Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key CRISPR-Based Therapeutics Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top CRISPR-Based Therapeutics Market Players by Market Size
3.1.1 Global Top CRISPR-Based Therapeutics Market Players by Revenue (2015-2020)
3.1.2 Global CRISPR-Based Therapeutics Market Revenue Market Share by Players (2015-2020)
3.1.3 Global CRISPR-Based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global CRISPR-Based Therapeutics Market Concentration Ratio
3.2.1 Global CRISPR-Based Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by CRISPR-Based Therapeutics Market Revenue in 2019
3.3 CRISPR-Based Therapeutics Market Key Players Head office and Area Served
3.4 Key Players CRISPR-Based Therapeutics Market Product Solution and Service
3.5 Date of entering into CRISPR-Based Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global CRISPR-Based Therapeutics Market Historic Market Size by Type (2015-2020)
4.2 Global CRISPR-Based Therapeutics Market Forecasted Market Size by Type (2021-2026)
5 CRISPR-Based Therapeutics Market Breakdown Data by Application (2015-2026)
5.1 Global CRISPR-Based Therapeutics Market Size by Application (2015-2020)
5.2 Global CRISPR-Based Therapeutics Market Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America CRISPR-Based Therapeutics Market Size (2015-2020)
6.2 CRISPR-Based Therapeutics Market Key Players in North America (2019-2020)
6.3 North America CRISPR-Based Therapeutics Market Size by Type (2015-2020)
6.4 North America CRISPR-Based Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe CRISPR-Based Therapeutics Market Size (2015-2020)
7.2 CRISPR-Based Therapeutics Market Key Players in Europe (2019-2020)
7.3 Europe CRISPR-Based Therapeutics Market Size by Type (2015-2020)
7.4 Europe CRISPR-Based Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China CRISPR-Based Therapeutics Market Size (2015-2020)
8.2 CRISPR-Based Therapeutics Market Key Players in China (2019-2020)
8.3 China CRISPR-Based Therapeutics Market Size by Type (2015-2020)
8.4 China CRISPR-Based Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan CRISPR-Based Therapeutics Market Size (2015-2020)
9.2 CRISPR-Based Therapeutics Market Key Players in Japan (2019-2020)
9.3 Japan CRISPR-Based Therapeutics Market Size by Type (2015-2020)
9.4 Japan CRISPR-Based Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia CRISPR-Based Therapeutics Market Size (2015-2020)
10.2 CRISPR-Based Therapeutics Market Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia CRISPR-Based Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia CRISPR-Based Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India CRISPR-Based Therapeutics Market Size (2015-2020)
11.2 CRISPR-Based Therapeutics Market Key Players in India (2019-2020)
11.3 India CRISPR-Based Therapeutics Market Size by Type (2015-2020)
11.4 India CRISPR-Based Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America CRISPR-Based Therapeutics Market Size (2015-2020)
12.2 CRISPR-Based Therapeutics Market Key Players in Central & South America (2019-2020)
12.3 Central & South America CRISPR-Based Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America CRISPR-Based Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 CRISPR-Based Therapeutics Market Introduction
13.4 CRISPR-Based Therapeutics Market Business (2015-2020)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. CRISPR-Based Therapeutics Market Key Market Segments
Table 2. Key Players Covered: Ranking by CRISPR-Based Therapeutics Market Revenue
Table 3. Ranking of Global Top CRISPR-Based Therapeutics Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CRISPR-Based Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for CRISPR-Based Therapeutics Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for CRISPR-Based Therapeutics Market Players to Combat Covid-19 Impact
Table 10. Global CRISPR-Based Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global CRISPR-Based Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global CRISPR-Based Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global CRISPR-Based Therapeutics Market Share by Regions (2015-2020)
Table 14. Global CRISPR-Based Therapeutics Market Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global CRISPR-Based Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. CRISPR-Based Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key CRISPR-Based Therapeutics Market Players
Table 21. Global CRISPR-Based Therapeutics Market Revenue by Players (2015-2020) (Million US$)
Table 22. Global CRISPR-Based Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top CRISPR-Based Therapeutics Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR-Based Therapeutics Market as of 2019)
Table 24. Global CRISPR-Based Therapeutics Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players CRISPR-Based Therapeutics Market Product Solution and Service
Table 27. Date of entering into CRISPR-Based Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global CRISPR-Based Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global CRISPR-Based Therapeutics Market Revenue Market Share by Type (2021-2026)
Table 31. Global CRISPR-Based Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global CRISPR-Based Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players CRISPR-Based Therapeutics Market Revenue (2019-2020) (Million US$)
Table 36. North America Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 37. North America CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 39. North America CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players CRISPR-Based Therapeutics Market Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 43. Europe CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 45. Europe CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players CRISPR-Based Therapeutics Market Revenue (2019-2020) (Million US$)
Table 48. China Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 49. China CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 51. China CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players CRISPR-Based Therapeutics Market Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 55. Japan CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 57. Japan CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players CRISPR-Based Therapeutics Market Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players CRISPR-Based Therapeutics Market Revenue (2019-2020) (Million US$)
Table 66. India Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 67. India CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 69. India CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players CRISPR-Based Therapeutics Market Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 73. Central & South America CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in CRISPR-Based Therapeutics Market Business (2015-2020) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global CRISPR-Based Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Global CRISPR-Based Therapeutics Market Share by Application: 2020 VS 2026
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. CRISPR-Based Therapeutics Market Report Years Considered
Figure 8. Global CRISPR-Based Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global CRISPR-Based Therapeutics Market Share by Regions: 2020 VS 2026
Figure 10. Global CRISPR-Based Therapeutics Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global CRISPR-Based Therapeutics Market Share by Players in 2019
Figure 13. Global Top CRISPR-Based Therapeutics Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR-Based Therapeutics Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by CRISPR-Based Therapeutics Market Revenue in 2019
Figure 15. North America CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
Request Discount 
Inquire Before Buy
